March 30 (Reuters) - Lipella Pharmaceuticals Inc LIPO.PK:
LIPELLA PHARMACEUTICALS INC. FILES VOLUNTARY PETITIONS FOR RELIEF UNDER CHAPTER 11
LIPELLA PHARMACEUTICALS INC: INTENDS TO UNDERGO A 363 SALE PROCESS UNDER CHAPTER 11
LIPELLA PHARMACEUTICALS INC: EXPECTS TO SEEK CUSTOMARY "FIRST-DAY" RELIEF THAT, IF APPROVED BY COURT, WOULD ALLOW IT TO CONTINUE DAY-TO-DAY OPERATIONS